{ }
Very Negative
Negative
Neutral
Positive
Very Positive
2025-04-202025-04-202025-04-212025-04-212025-04-222025-04-222025-04-232025-04-2312682816161212884400
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-04-202025-04-202025-04-212025-04-212025-04-222025-04-222025-04-232025-04-23121421285116161212884400
Download SVG
Download PNG
Download CSV

abbott laboratories receives buy rating from ubs amid strong product sales

Abbott Laboratories, a leader in pharmaceutical and medical product development, has received a Buy rating from UBS. The company's net sales are primarily derived from diagnostic systems (39.1%) and vascular devices (24.7%), with significant contributions from nutritional products (12.1%) and medical products (8.2%). Geographically, the United States accounts for 38.5% of sales, followed by Germany (5.8%) and China (5.6%).
17:14 17.10.2024

us healthcare system ranks last in access equity and outcomes

The U.S. healthcare system ranks last among 10 countries in access, equity, and outcomes, despite spending over 16% of its GDP on healthcare. Key issues include high costs, a fragmented insurance system, and significant numbers of uninsured and underinsured individuals, leading to poor health outcomes and limited access to care. Recommendations for improvement include extending coverage to the uninsured, reducing administrative complexity, and investing in public health.

Zur Rose Group AG faces challenges in pharmaceutical distribution sector

Zur Rose Group AG, a Swiss pharmaceutical distribution company, operates through two divisions: Zur Rose, which focuses on wholesale medicine supply to healthcare providers, and DocMorris, which manages mail-order pharmacy sales. The company serves markets in Switzerland, Germany, and the Netherlands via subsidiaries including Zur Rose Suisse AG and DocMorris NV.
11:39 17.10.2024

just eat takeaway.com expands global online food delivery marketplace

Just Eat Takeaway.com N.V., headquartered in Amsterdam, is a prominent global online food delivery marketplace, connecting consumers with over 699,000 restaurant partners. The company operates in various regions, including North America, Northern Europe, the UK, Southern Europe, Australia, and New Zealand, offering a diverse range of food choices and delivery services.
11:39 17.10.2024

ubs maintains buy rating for just eat takeaway despite modest growth

UBS has maintained a 'Buy' rating for Just Eat Takeaway following the release of third-quarter figures. Analyst Jo Barnet-Lamb noted that while the food supplier's growth was modest, its profitability remains positive.
11:39 17.10.2024

ubs maintains buy rating for just eat takeaway despite modest growth

UBS has maintained a 'Buy' rating for Just Eat Takeaway following the release of third-quarter figures. Analyst Jo Barnet-Lamb noted that while the food supplier's growth was modest, its profitability remains positive.
11:39 17.10.2024

ubs downgrades moller maersk to neutral with target of 11000 kroner

UBS has downgraded A.P. Moller-Maersk from "Buy" to "Neutral," reducing the price target from 13,953 to 11,000 Danish kroner. Analyst Cristian Nedelcu noted that the shares face challenges due to concerns over medium-term overcapacity in the shipping sector and capital usage.
11:08 17.10.2024

just eat takeaway receives buy rating from ubs amid stock decline

UBS has rated Just Eat Takeaway as a 'Buy' despite a recent decline in its stock price, which fell by 3.56% to €10.97. The stock has seen fluctuations across various trading platforms, with prices ranging from €10.01 to a high of €15.95 over the year.
10:53 17.10.2024

ubs lowers abn amro price target while maintaining buy recommendation

UBS has reaffirmed its 'buy' recommendation on ABN Amro while lowering its price target from 19.5 to 18.1 euros, indicating a potential upside of 17% for the stock. The revision comes ahead of the third-quarter results, reflecting adjustments in EPS forecasts for 2025 and beyond due to lower interest rates, increased costs, and recent AT1 issues.
10:16 17.10.2024

ubs lowers abn amro price target while maintaining buy recommendation

UBS has reaffirmed its 'buy' recommendation on ABN Amro while lowering its price target from €19.5 to €18.1, indicating a potential upside of 17% for the stock. The broker anticipates double-digit EPS revisions for 2025 and beyond, influenced by lower interest rates, increased costs, and recent AT1 issues.
10:13 17.10.2024
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.